Analysis of immunoglobulin (Ig) variable (VH) region mutational status and CD38 phenotype for B-CLL patients entered on north central cancer chemotherapy trials group (NCCTG) clinical trials.

被引：0

|

作者：

Jelinek, DF ^{[1
]}

Hanson, CA ^{[1
]}

Dewald, GW ^{[1
]}

Witzig, TE ^{[1
]}

Bone, ND ^{[1
]}

Geyer, SM ^{[1
]}

Tefferi, A ^{[1
]}

Stenson, MJ ^{[1
]}

Tschumper, RC ^{[1
]}

Kay, NE ^{[1
]}

机构：

[1] Mayo Clin, Rochester, MN USA

来源：

BLOOD | 2000年 / 96卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3608

引用

收藏

页码：835A / 835A

页数：1

相关论文

共 4 条

[1] B-CLL patients can be divided into two distinct clinical categories based on CD38 expression and Ig V gene mutation status.
Damle, RN
Fais, F
Wasil, T
Allen, SL
Buchbinder, A
Budman, DR
Schulman, P
Rai, KR
Vinciguerra, VP
Ferrarini, M
Chiorazzi, N
BLOOD, 1998, 92 (10) : 431A - 431A
[2] Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia
Jelinek, DF
Tschumper, RC
Geyer, SM
Bone, ND
Dewald, GW
Hanson, CA
Stenson, MJ
Witzig, TE
Tefferi, A
Kay, NE
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (04) : 854 - 861
[3] Incidence of bleeding and thrombosis among elderly patients (pts) undergoing systemic chemotherapy in advanced non-small cell lung cancer (NSCLC): An analysis of North Central Cancer Treatment Group (NCCTG) trials.
Qi, Y.
Dy, G. K.
Nelson, G. D.
Schild, S. E.
Mandrekar, S. J.
Adjei, A. A.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[4] A patient-level pooled analysis of the prognostic significance of baseline fatigue for overall survival (OS) among 3,915 patients participating in 43 North Central Cancer Treatment Group (NCCTG) and Mayo Clinic Cancer Center (MC) oncology clinical trials
Sloan, J. A.
Liu, H.
Sargent, D. J.
Satele, D.
Schaefer, P. L.
Halyard, M. Y.
Grothey, A.
Garces, Y. I.
Brown, P. D.
Loprinzi, C. L.
Buckner, J. C.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)